DOI QR코드

DOI QR Code

A Study on Weight Loss Effect and Safety of Integrated Korean Medicine Treatment on Obese Patients in Local Clinics: A Restrospective Chart Review

한의원 진료환경에서 비만환자 대상 한의통합치료의 체중 감량 효과 및 안전성에 관한 연구: 후향적 차트 리뷰

  • Ojin, Kwon (Korean Medicine Science Research Division, Korea Institute of Oriental Medicine) ;
  • Changsop, Yang (Korean Medicine Science Research Division, Korea Institute of Oriental Medicine) ;
  • Young Jin, Kim (The Association of Korean Medicine, Daejeon Metropolitan City Branch) ;
  • Won Hae, Ku (The Association of Korean Medicine, Daejeon Metropolitan City Branch) ;
  • Won Gu, Lee (The Association of Korean Medicine, Daejeon Metropolitan City Branch) ;
  • Ki Byung, Kim (The Association of Korean Medicine, Daejeon Metropolitan City Branch) ;
  • Kyung Hwan, Jegal (Digital Health Research Division, Korea Institute of Oriental Medicine)
  • 권오진 (한국한의학연구원 한의과학연구부) ;
  • 양창섭 (한국한의학연구원 한의과학연구부) ;
  • 김용진 (대전광역시 한의사협회) ;
  • 구원회 (대전광역시 한의사협회) ;
  • 이원구 (대전광역시 한의사협회) ;
  • 김기병 (대전광역시 한의사협회) ;
  • 제갈경환 (한국한의학연구원 디지털임상연구부)
  • Received : 2022.08.01
  • Accepted : 2022.08.31
  • Published : 2022.12.30

Abstract

Objectives: A restrospective chart review were conducted to investigate the overall weight loss effect of the integrated Korean medicine treatment on obese patients (body mass index [BMI] ≥25 kg/m2) in Korean medicine clinic and analyze the difference in the effect according to lifestyle behaviors. Methods: The medical records of 43 obese patients were retrospectively analyzed including body weight, BMI, waist circumference, hip circumference, and body composition who received integrated Korean medicine treatment for 4 weeks at 24 Korean medicine clinics in Daejeon metropolitan city. All outcome measures were evaluated again 8 weeks after the end of treatment at week 12 for follow-up. EuroQol-5D (EQ-5D), the Korean version of the obesity-related quality of life scale (KOQOL) and patient's satisfaction were also evaluated. The analysis was divided according to the treatment period and observation period, and subgroup analysis was performed according to drinking and exercise habits. Results: Body weight, body fat, waist circumference, hip circumference, body fat were significantly reduced at week 4 and week 12. Theses weight reduction effects were significantly greater within treatment period (0 to 4 week) than observation period (4 to 12 week). Especially in the non-exercise group, the changes in body fat mass and body fat percent showed a significant difference between the treatment period and the observation period. KOQOL were also significantly improved at 12 week, but not in EQ-5D. No severe adverse events were observed. Conclusions: The integrated Korean medicine treatment could be effective to treat obesity including weight loss. It is necessary to prevent additional weight regain through regular exercise even after Korean medicine treatment.

Keywords

Acknowledgement

본 연구는 한국한의학연구원(KSN2022210)의 지원으로 수행되었으며, 연구 수행에 도움을 주신 대전광역시 한의사협회 및 소속 24개 한의원 관계자에게 감사의 말씀을 전합니다.

References

  1. Korean National Health Insurance Service. The 2018 obesity white book. Wonju : Korean National Health Insurance Service. 2018 : 208.
  2. Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee SS, et al. Obesity fact sheet in Korea, 2020: Prevalence of obesity and abdominal obesity from 2009 to 2018 and social factors. J Obes Metab Syndr. 2021 ; 30(2) : 141-8. https://doi.org/10.7570/jomes21056
  3. Baik I. Forecasting obesity prevalence in Korean adults for the years 2020 and 2030 by the analysis of contributing factors. Nutr Res Pract. 2018 ; 12(3) : 251-7. https://doi.org/10.4162/nrp.2018.12.3.251
  4. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean society for the study of obesity guideline for the management of obesity in Korea. J Obes Metab Syndr. 2019 ; 28(1) : 40-5. https://doi.org/10.7570/jomes.2019.28.1.40
  5. National Institute of Korean Medicine Development. Survey on the use of tradtional Korean medicine and comsumption of herbal medicine 2020. Gyeongsan : National Institute of Korea Medicine Development. 2021.
  6. Azushima K, Tamura K, Haku S, Wakui H, Kanaoka T, Ohsawa M, et al. Effects of the oriental herbal medicine bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ath-d-14-01021.R2). Atherosclerosis. 2015 ; 240(1) : 297-304. https://doi.org/10.1016/j.atherosclerosis.2015.01.025
  7. Li JE, Song YK, Lim HH. Clinical trial of taeeumjowui-tang (taiyintiaowei-tang) on obese patients-randomized, double blind, placebo-controlled study. J Oriental Rehab Med. 2010 ; 20(4) : 197-213.
  8. Cheon C, Song YK, Ko SG. Efficacy and safety of euiiyin-tang in korean women with obesity: a randomized, double-blind, placebo-controlled, multicenter trial. Complement Ther Med. 2020 ; 51 : 102423.
  9. Seo DM, Lee SH, Lee JD. Clinical observation on effects and adverse effects of choweseuncheng-tang on obesity patients. J Acupunct Res. 2005 ; 22(3) : 145-54.
  10. Fang S, Wang M, Zheng Y, Zhou S, Ji G. Acupuncture and lifestyle modification treatment for obesity: a meta-analysis. Am J Chin Med. 2017 ; 45(2) : 239-54. https://doi.org/10.1142/s0192415x1750015x
  11. Kim SH, Han KS, Kwon OJ, Lee WG, Yoon CS, Lee JH. Effect of Korean medicine treatment including Korean medicine counselling on weight loss in patients with morbid obesity: a retrospective chart review. J Korean Med Obes Res. 2021 ; 21(1) : 22-31. https://doi.org/10.15429/jkomor.2021.21.1.22
  12. Chung WS, Kim KW, Jo JY, Kim H. Development of manual for standard counseling of obesity patients in Korean medicine. J Korean Med Obes Res. 2019 ; 19(2) : 113-8. https://doi.org/10.15429/jkomor.2019.19.2.113
  13. World Health Organization. Regional office for the western pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney : Health Communications Australia. World Health Organization. 2000.
  14. Kang KW, Moon JS, Kang BG, Kim BY, Choi SM, Shin MS. Comparison of pattern identification diagnosis according to symptom scale based on obesity pattern identification questionnaire. J Korean Med Obes Res. 2009 ; 9(1) : 37-44.
  15. EQ-5D. EQ-5D product [Internet]. Rotterdam: EuroQol; 2022 [cited 2022 Aug 31]. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/.
  16. Lee SI. Validity and reliability evaluation for EQ-5D in Korea. Korea Disease Control and Prevention Agency. 2011.
  17. Park HS, Sung SW, Ou SW, Lee KY, Kim BS, Han JH, et al. Development of Korean version of obesity-related quality of life scale. Korean J Obes. 2003 ; 12(4) : 280-92.
  18. Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017 ; 6(2) : 187-94. https://doi.org/10.1007/s13679-017-0262-y
  19. Jung HG, Jeong HS. Factors related to successful weight reduction among subjects who tried to reduce their weight for 1 year: data from the 2015 Korea national health and nutrition examination survey. J Health Info Stat. 2017 ; 42(4) : 355-60. https://doi.org/10.21032/jhis.2017.42.4.355
  20. Jegal KH, Ko MM, Kim BY, Son MJ, Kim S. A national survey on current clinical practice pattern of Korean Medicine doctors for treating obesity. PLoS One. 2022 ; 17(3) : e0266034.
  21. Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017 ; 8(3) : 511-9. https://doi.org/10.3945/an.116.014506
  22. Duan T, Kang JW, Lee S, Lee W, Jeoung J, Cha Y. Analysis of research trend about Jowiseungcheong-tang (Diaoweishengqing-tang) for treating obesity and metabolic disease: focused on domestic journals. J Korean Med Rehabi. 2021 ; 31(4) : 13-23. https://doi.org/10.18325/jkmr.2021.31.4.13
  23. Song MR, Lee HW, Jo JY, Kim EK. Analysis of women's body mass index, weight perception and obesity-related quality of life. J Korean Acad Fundam Nurs. 2010 ; 17(3) : 419-26.
  24. Kim JH. Association between body shape Index, perceived body shape and self-rated health, quality of life in korean adults population using sixth Korea National Health and Nutrition Examination Survey. Health Soc Welfare Rev. 2018 ; 38(4) : 323-40.